Rapid hemostasis of arterial puncture sites with Angio-Seal in patients undergoing percutaneous coronary intervention

Hanafi B Trisnohadi1

  • 1Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Dr. Cipto Mangunkusumo Hospital, Jakarta.

Acta Medica Indonesiana
|January 14, 2010
PubMed

Insights

The Angio-Seal device significantly speeds up hemostasis after percutaneous coronary intervention (PCI), reducing patient immobilization time. This vascular closure device offers a safe and efficient alternative to manual compression for PCI access sites.

Area of Science:

  • Cardiovascular Interventions
  • Vascular Access Management
  • Medical Device Technology

Background:

  • Percutaneous coronary intervention (PCI) requires effective management of arterial access sites to ensure patient safety and facilitate recovery.
  • Traditional manual compression for hemostasis can lead to prolonged immobilization and potential complications.
  • The Angio-Seal device is designed to provide rapid and reliable hemostasis following vascular access procedures.

Purpose of the Study:

  • To compare the efficacy and safety of the Angio-Seal device versus manual compression for achieving hemostasis after PCI.
  • To evaluate the impact of the Angio-Seal device on key recovery metrics, including time to hemostasis and ambulation.

Main Methods:

  • A comparative study involving 176 patients undergoing PCI (88 Angio-Seal, 88 manual compression) between December 2002 and November 2003.
  • Key outcome measures included time to hemostasis, time to ambulation, and incidence of groin complications.
  • Patient demographics and activated clotting times were recorded for comparative analysis.

Main Results:

  • Angio-Seal significantly reduced time to hemostasis (1.5 vs. 38.1 minutes, p < 0.0001) compared to manual compression, even with higher activated clotting times.
  • Patients treated with Angio-Seal experienced shorter leg immobilization (4-6 hours) and significantly earlier ambulation (5.2 hours) versus manual compression (10-14 hours, 13.0 hours).
  • No significant difference in overall major complication rates was observed between the Angio-Seal and manual compression groups.

Conclusions:

  • The Angio-Seal device facilitates rapid hemostasis at arterial puncture sites following PCI.
  • Utilizing the Angio-Seal device leads to substantially shorter ambulation times compared to manual compression.
  • The study supports the Angio-Seal device as a safe and effective option for vascular access closure post-PCI, without increasing groin complications.
Abstract

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...